CNS Co (4076) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
22 Jul, 2026Executive summary
Revenue for the six months ended November 30, 2024, increased 2.0% year-over-year to ¥3,364 million, driven by growth in digital transformation and big data businesses.
Operating income declined 30.0% year-over-year to ¥226 million due to higher personnel costs and increased outsourcing fees.
Net income attributable to shareholders fell 26.4% year-over-year to ¥162 million, reflecting increased labor costs and a rise in SG&A ratio.
The company continues to invest in DX, AI, and consulting capabilities, while facing a tight IT labor market.
Financial highlights
Revenue: ¥3,364 million (+2.0% YoY); Operating income: ¥226 million (−30.0% YoY); Ordinary income: ¥240 million (−28.7% YoY); Net income: ¥162 million (−26.4% YoY).
EPS for the period was ¥55.82, down from ¥75.82 in the prior year.
Gross margin declined as personnel expenses rose by approximately 11%, increasing labor cost ratio by 2.6 points YoY.
Outlook and guidance
Full-year revenue forecast remains unchanged at ¥7,562 million (+13.6% YoY), with operating income projected at ¥660 million (+6.6% YoY) and net income at ¥489 million (+6.2% YoY).
No revision to previously announced guidance; management states business progress is on track.
Latest events from CNS Co
- Double-digit revenue growth driven by DX and consulting, with profit growth to continue.4076
Q4 202422 Jul 2026 - Profit dropped sharply in Q1 FY2025 despite stable revenue, as labor costs surged.4076
Q1 202522 Jul 2026 - Revenue up 4.1% year-over-year, but profit margins declined on higher personnel costs.4076
Q3 202522 Jul 2026 - Revenue up 5.2% year-over-year, but profit margins declined amid higher costs and investments.4076
Q4 202522 Jul 2026 - Q1 FY2026 delivered double-digit profit growth, with all segments contributing to higher earnings.4076
Q1 202622 Jul 2026 - Revenue and profits surged on robust DX/AI demand, prompting an upward revision to full-year guidance.4076
Q2 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI demand, with upwardly revised full-year outlook.4076
Q3 202622 Jul 2026 - Strong revenue and profit growth driven by DX/AI, with double-digit gains and robust FY2027 outlook.4076
Q4 202622 Jul 2026